1. Otranto 27 gennaio 2012MECCANISMI DI RESISTENZA AI FARMACINEL mRCC Michele Guida Dipartimento di Oncologia MedicaIstituto dei Tumori Bari 2. Drugs Resistance in mRCC1.…

Slide 1Measuring Angiogenesis in Hematologic Diseases Maher Albitar, MD Quest Diagnostics, Nichols Institute San Juan Capistrano, CA 92690 (949)728-4784 [email protected]…

Slide 1Dynamic CT imaging (DCE-CT) in the anti-angiogenic response in Metastatic Renal Cell Carcinoma Prof. C A Cuenod, L Fournier, G Frija Laboratoire de Recherche en Imagerie,…

Endothelial precursors (angioblasts) in the embryo assemble in a primitive network (vasculogenesis), that expands and remodels (angiogenesis). Smooth muscle cells cover endothelial…

Slide 1Multifaceted immunotherapeutic effects of vitamin D-binding protein-derived macrophage activating factor (GcMAF) on human breast cancer cells Pacini S*, Ward E**,…

Slide 1 ◎ Research Field : Molecular Pathophysiology Cancer Biology, Angiogenic Diseases ◎ Present - Dean, Professor, KNU, College of Pharmacy  Chairperson, KSMCB…

Slide 1 IMAGING in ONCOLOGY Biomedical Engineering P Verdonck D De Naeyer S Staelens Gastro-oncology M Peeters N Van Damme V Casneuf Radiology P Smeets Radiotherapy T Boterberg…

Slide 1 23.04.2014 Roberto Carlos Moreno Martín-Bejarano Health and Disease Cancer Slide 2 A) Introduction: Answer the questions of the video. http://www.youtube.com/watch?v=46Xh7OFkkCE…

Bevacizumab: Antiangiogenic therapy for breast cancer: where do we stand? Fortunato Ciardiello Division of Medical Oncology, Department of Clinical and Experimental Medicine,…

Anti-angiogenic therapy: a new approach to the treatment of metastatic breast cancer Kathy Miller Indiana University School of Medicine, USA VEGF is a central mediator of…